New MASH drug enters early human testing
Disease control
Recruiting now
This early-stage study tests an investigational drug called TGM-312-SC01 in healthy volunteers and people with MASH, a serious liver condition. The main goal is to check the drug's safety and how the body processes it. About 99 participants will receive either the drug or a place…
Phase: PHASE1, PHASE2 • Sponsor: Tangram Therapeutics Plc • Aim: Disease control
Last updated May 01, 2026 16:00 UTC